pubmed-article:8039162 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8039162 | lifeskim:mentions | umls-concept:C0370003 | lld:lifeskim |
pubmed-article:8039162 | lifeskim:mentions | umls-concept:C0033578 | lld:lifeskim |
pubmed-article:8039162 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
pubmed-article:8039162 | lifeskim:mentions | umls-concept:C0162789 | lld:lifeskim |
pubmed-article:8039162 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:8039162 | pubmed:dateCreated | 1994-8-25 | lld:pubmed |
pubmed-article:8039162 | pubmed:abstractText | Analysis of 20 primary prostatic tumors (local Gleason grades ranging from 1 to 4) was performed on archival material obtained from formalin-fixed, paraffin-embedded blocks. Alpha satellite probes specific for the pericentric regions of chromosomes 12, 17, X, and Y were used in fluorescence in situ hybridization (FISH) assays for the examination of aneusomies for these chromosomes. Eighty percent of specimens (16/20) showed significant loss of chromosome 17 and 55% (11/20 specimens) also showed significant loss of chromosome 12; all specimens that lost chromosome 12 lost chromosome 17. Gain of the X chromosome was observed in 40% (8/20) of specimens, all but one of which also showed loss of chromosome 17. While the specimens showing gain of the X chromosome may represent polyploid cells, only one specimen also showed significant gain of chromosomes 12 and 17, suggesting that both of these chromosomes may be lost in hyperdiploid prostate cancers. Loss of the Y chromosome was not statistically significant. This study thus indicates that loss of chromosome 17 is a frequent and likely early event in prostatic cancer. | lld:pubmed |
pubmed-article:8039162 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8039162 | pubmed:language | eng | lld:pubmed |
pubmed-article:8039162 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8039162 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8039162 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8039162 | pubmed:month | Jul | lld:pubmed |
pubmed-article:8039162 | pubmed:issn | 0165-4608 | lld:pubmed |
pubmed-article:8039162 | pubmed:author | pubmed-author:LueS LSL | lld:pubmed |
pubmed-article:8039162 | pubmed:author | pubmed-author:WilliamsB JBJ | lld:pubmed |
pubmed-article:8039162 | pubmed:author | pubmed-author:WatsonM JMJ | lld:pubmed |
pubmed-article:8039162 | pubmed:author | pubmed-author:BrothmanA RAR | lld:pubmed |
pubmed-article:8039162 | pubmed:author | pubmed-author:RohrL RLR | lld:pubmed |
pubmed-article:8039162 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8039162 | pubmed:day | 1 | lld:pubmed |
pubmed-article:8039162 | pubmed:volume | 75 | lld:pubmed |
pubmed-article:8039162 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8039162 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8039162 | pubmed:pagination | 40-4 | lld:pubmed |
pubmed-article:8039162 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:8039162 | pubmed:meshHeading | pubmed-meshheading:8039162-... | lld:pubmed |
pubmed-article:8039162 | pubmed:meshHeading | pubmed-meshheading:8039162-... | lld:pubmed |
pubmed-article:8039162 | pubmed:meshHeading | pubmed-meshheading:8039162-... | lld:pubmed |
pubmed-article:8039162 | pubmed:meshHeading | pubmed-meshheading:8039162-... | lld:pubmed |
pubmed-article:8039162 | pubmed:meshHeading | pubmed-meshheading:8039162-... | lld:pubmed |
pubmed-article:8039162 | pubmed:meshHeading | pubmed-meshheading:8039162-... | lld:pubmed |
pubmed-article:8039162 | pubmed:meshHeading | pubmed-meshheading:8039162-... | lld:pubmed |
pubmed-article:8039162 | pubmed:meshHeading | pubmed-meshheading:8039162-... | lld:pubmed |
pubmed-article:8039162 | pubmed:meshHeading | pubmed-meshheading:8039162-... | lld:pubmed |
pubmed-article:8039162 | pubmed:meshHeading | pubmed-meshheading:8039162-... | lld:pubmed |
pubmed-article:8039162 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:8039162 | pubmed:articleTitle | Evaluation of 20 archival prostate tumor specimens by fluorescence in situ hybridization (FISH). | lld:pubmed |
pubmed-article:8039162 | pubmed:affiliation | Department of Human Genetics, University of Utah School of Medicine, Salt Lake City 84112. | lld:pubmed |
pubmed-article:8039162 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8039162 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:8039162 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8039162 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8039162 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8039162 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8039162 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8039162 | lld:pubmed |